Eli Lilly Gets European Approval to Sell Trulicity, a Type 2 Diabetes Drug


Log in to manage your products and services from The New York Times and the International New York Times.

Don’t have an account yet?
Create an account »

Subscribed through iTunes and need an NYTimes.com account?
Learn more »